Tag Archives: Yunnan

COVID-19 vaccine reaches phase-2 trials in China

An inactivated COVID-19 vaccine candidate developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences has entered phase-2 clinical trials in China, the Science and Technology Daily reported Saturday. The phase-2 trials, which further evaluate the immunogenicity and safety of the vaccine in humans, are conducted …

Read More »